S100A4 and pachyonychia congenita: A meta-analysis of 474 patients with PC indicated that S100A4 is a potential adverse factor in PC prognosis, whose positive expression is considerably related to a lower 3-year OS rate (50), suggesting that S100A4 may be a potential indicator to predict the survival rate of patients (44, 48).